Header Logo
Last Name

Dr Ahmed Mudawi Musa

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Salih MA, Fakiola M, Abdelraheem MH, Younis BM, Musa AM, ElHassan AM, Blackwell JM, Ibrahim ME, Mohamed HS. Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients. BMC Infect Dis. 2014 Dec 03; 14:662. PMID: 25466928; PMCID: PMC4265480.
    2. Ahmed AM, Kadaru AG, Omer I, Musa AM, Enan K, El Khidir IM, Williams R. Macrophages from patients with cirrhotic ascites showed function alteration of host defense receptor. J Clin Exp Hepatol. 2014 Dec; 4(4):279-86. PMID: 25755574; PMCID: PMC4298631.
    3. Magaji MG, Yakubu Y, Magaji RA, Musa AM, Yaro AH, Hussaini IM. Psychopharmacological potentials of methanol leaf extract of Securinega virosa Roxb (Ex Willd) Baill. in mice. Pak J Biol Sci. 2014 Jun; 17(6):855-9. PMID: 26035960.
      View in: PubMed
    4. A AO, M MM, A HA, Elamin MY, Younis BM, E ME, Musa AM, Elhassan AM, G EA. Visceral leishmaniasis-hepatitis B/C coinfections: a rising necessity to triage patients for treatment. Ann Saudi Med. 2014 Mar-Apr; 34(2):143-6. PMID: 24894783.
      View in: PubMed
    5. Khalil EA, Weldegebreal T, Younis BM, Omollo R, Musa AM, Hailu W, Abuzaid AA, Dorlo TP, Hurissa Z, Yifru S, Haleke W, Smith PG, Ellis S, Balasegaram M, EL-Hassan AM, Schoone GJ, Wasunna M, Kimutai R, Edwards T, Hailu A. Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial. PLoS Negl Trop Dis. 2014; 8(1):e2613. PMID: 24454970; PMCID: PMC3894173.
    6. Shakak AO, Khalil EA, Musa AM, Salih KA, Bashir AE, Ahmed AH, Idris FE, Elhassan AM. Prevalence of latent tuberculosis infection in Sudan: a case-control study comparing interferon-? release assay and tuberculin skin test. BMC Public Health. 2013 Dec 05; 13:1128. PMID: 24313987; PMCID: PMC4029475.
    7. Meheus F, Abuzaid AA, Baltussen R, Younis BM, Balasegaram M, Khalil EA, Boelaert M, Musa AM. The economic burden of visceral leishmaniasis in Sudan: an assessment of provider and household costs. Am J Trop Med Hyg. 2013 Dec; 89(6):1146-53. PMID: 24189368; PMCID: PMC3854893.
    8. Musa AM, Khalil EA, Younis BM, Elfaki ME, Elamin MY, Adam AO, Mohamed HA, Dafalla MM, Abuzaid AA, El-Hassan AM. Treatment-based strategy for the management of post-kala-azar dermal leishmaniasis patients in the Sudan. J Trop Med. 2013; 2013:708391. PMID: 23690794; PMCID: PMC3649346.
    9. Khalil EA, Khidir SA, Musa AM, Musa BY, Elfaki ME, Elkadaru AM, Zijlstra E, El-Hassan AM. Post-Kala-Azar Dermal Leishmaniasis: A Paradigm of Paradoxical Immune Reconstitution Syndrome in Non-HIV/AIDS Patients. J Trop Med. 2013; 2013:275253. PMID: 23634148; PMCID: PMC3619621.
    10. Alkadarou T, Musa A, Alkadarou A, Mahfouz MS, Troye-Blomberg M, Elhassan AM, Elhassan IM. Immunological characteristics of hyperreactive malarial splenomegaly syndrome in sudanese patients. J Trop Med. 2013; 2013:961051. PMID: 23533445; PMCID: PMC3603278.
    11. El Hassan AM, Khalil EA, Elamin WM, El Hassan LA, Ahmed ME, Musa AM. Misdiagnosis and mistreatment of post-kala-azar dermal leishmaniasis. Case Rep Med. 2013; 2013:351579. PMID: 23533426; PMCID: PMC3600135.
    12. Musa MM, Elamin KM, Ati KA, Elagib HA, Musa AM. Effect of dietary levels of decorticated cow pea (Vigna unguiculata) supplemented with molasses on broiler chicks performance and carcass traits. Pak J Biol Sci. 2012 Nov 01; 15(21):1010-8. PMID: 24163943.
      View in: PubMed
    13. Elfaki ME, Khalil EA, De Groot AS, Musa AM, Gutierrez A, Younis BM, Salih KA, El-Hassan AM. Immunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccines. Hum Vaccin Immunother. 2012 Dec 01; 8(12):1769-74. PMID: 22922767; PMCID: PMC3656064.
    14. Musa A, Khalil E, Hailu A, Olobo J, Balasegaram M, Omollo R, Edwards T, Rashid J, Mbui J, Musa B, Abuzaid AA, Ahmed O, Fadlalla A, El-Hassan A, Mueller M, Mucee G, Njoroge S, Manduku V, Mutuma G, Apadet L, Lodenyo H, Mutea D, Kirigi G, Yifru S, Mengistu G, Hurissa Z, Hailu W, Weldegebreal T, Tafes H, Mekonnen Y, Makonnen E, Ndegwa S, Sagaki P, Kimutai R, Kesusu J, Owiti R, Ellis S, Wasunna M. Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial. PLoS Negl Trop Dis. 2012; 6(6):e1674. PMID: 22724029; PMCID: PMC3378617.
    15. Fakiola M, Miller EN, Fadl M, Mohamed HS, Jamieson SE, Francis RW, Cordell HJ, Peacock CS, Raju M, Khalil EA, Elhassan A, Musa AM, Silveira F, Shaw JJ, Sundar S, Jeronimo SM, Ibrahim ME, Blackwell JM. Genetic and functional evidence implicating DLL1 as the gene that influences susceptibility to visceral leishmaniasis at chromosome 6q27. J Infect Dis. 2011 Aug 01; 204(3):467-77. PMID: 21742847; PMCID: PMC3132144.
    16. Omollo R, Alexander N, Edwards T, Khalil EA, Younis BM, Abuzaid AA, Wasunna M, Njoroge N, Kinoti D, Kirigi G, Dorlo TP, Ellis S, Balasegaram M, Musa AM. Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial. Trials. 2011 Jun 30; 12:166. PMID: 21718522; PMCID: PMC3155829.
    17. Khalil EA, Musa AM, Younis BM, Elfaki ME, Zijlstra EE, Elhassan AM. Blindness following visceral leishmaniasis: a neglected post-kala-azar complication. Trop Doct. 2011 Jul; 41(3):139-40. PMID: 21676981.
      View in: PubMed
    18. Khalil EA, Elnour AA, Musa AM, Elagib AA, Hassab Elgawi SH, Ismail WM, Elzaki KE. Tuberculous lymphadenitis: skin delayed-type hypersensitivity reaction and cellular immune responses. West Afr J Med. 2011 May-Jun; 30(3):193-6. PMID: 22120485.
      View in: PubMed
    19. Edwards T, Omollo R, Khalil EA, Yifru S, Musa B, Musa A, Wasunna M, Smith PG, Royce C, Ellis S, Balasegaram M, Hailu A. Single-dose liposomal amphotericin B (AmBisome®) for the treatment of visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial. Trials. 2011 Mar 06; 12:66. PMID: 21375777; PMCID: PMC3061925.
    20. Musa AM, Younis B, Fadlalla A, Royce C, Balasegaram M, Wasunna M, Hailu A, Edwards T, Omollo R, Mudawi M, Kokwaro G, El-Hassan A, Khalil E. Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study. PLoS Negl Trop Dis. 2010 Oct 26; 4(10):e855. PMID: 21049063; PMCID: PMC2964291.
    21. Hailu A, Musa A, Wasunna M, Balasegaram M, Yifru S, Mengistu G, Hurissa Z, Hailu W, Weldegebreal T, Tesfaye S, Makonnen E, Khalil E, Ahmed O, Fadlalla A, El-Hassan A, Raheem M, Mueller M, Koummuki Y, Rashid J, Mbui J, Mucee G, Njoroge S, Manduku V, Musibi A, Mutuma G, Kirui F, Lodenyo H, Mutea D, Kirigi G, Edwards T, Smith P, Muthami L, Royce C, Ellis S, Alobo M, Omollo R, Kesusu J, Owiti R, Kinuthia J. Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial. PLoS Negl Trop Dis. 2010 Oct 26; 4(10):e709. PMID: 21049059; PMCID: PMC2964287.
    22. Elnojomi NA, Musa AM, Younis BM, Elfaki ME, El-Hassan AM, Khalil EA. Surrogate markers of subtle renal injury in patients with visceral leishmaniasis. Saudi J Kidney Dis Transpl. 2010 Sep; 21(5):872-5. PMID: 20814123.
      View in: PubMed
    23. Hamad SH, Khalil EA, Musa AM, Ibrahim ME, Younis BM, Elfaki ME, El-Hassan AM. Leishmania donovani: genetic diversity of isolates from Sudan characterized by PCR-based RAPD. Exp Parasitol. 2010 Aug; 125(4):389-93. PMID: 20346944.
      View in: PubMed
    24. Farouk S, Salih MA, Musa AM, Blackwell JM, Miller EN, Khalil EA, Elhassan AM, Ibrahim ME, Mohamed HS. Interleukin 10 gene polymorphisms and development of post kala-azar dermal leishmaniasis in a selected sudanese population. Public Health Genomics. 2010; 13(6):362-7. PMID: 20051670; PMCID: PMC2951725.
    25. Musa AM, Noazin S, Khalil EA, Modabber F. Immunological stimulation for the treatment of leishmaniasis: a modality worthy of serious consideration. Trans R Soc Trop Med Hyg. 2010 Jan; 104(1):1-2. PMID: 19712953.
      View in: PubMed
    26. Eni UE, Na'aya HU, Musa AM, Lawan MA, Chinda JY. An audit of non-fatal assault injuries treated in Federal Medical Center (FMC), Nguru, north east Nigeria. Niger J Med. 2009 Apr-Jun; 18(2):168-71. PMID: 19630322.
      View in: PubMed
    27. Nimir AA, Khalil EA, Musa AM, Yassin HM, El-Hassan AM. Evaluation of the particle gel diffusion technique for the detection of haemoglobin S in Sudanese patients. Ann Clin Biochem. 2009 Mar; 46(Pt 2):114-6. PMID: 19164340.
      View in: PubMed
    28. Elagib AH, Ahmed AE, Hussein A, Musa AM, Khalil EA, El-Hassan AM. Possible predisposing factors for thrombotic cerebrovascular accidents in Sudanese patients. Saudi Med J. 2008 Feb; 29(2):304-6. PMID: 18246249.
      View in: PubMed
    29. Khalil EA, Musa AM, Elgawi SH, Meshasha A, Gamar Eldawla I, Elhassan MO, Eljaleel KA, Younis BM, Elfaki ME, El-Hassan AM. Revival of a focus of visceral leishmaniasis in central Sudan. Ann Trop Med Parasitol. 2008 Jan; 102(1):79-80. PMID: 18186981.
      View in: PubMed
    30. Musa AM, Khalil EA, Mahgoub FA, Elgawi SH, Modabber F, Elkadaru AE, Aboud MH, Noazin S, Ghalib HW, El-Hassan AM. Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment. Trans R Soc Trop Med Hyg. 2008 Jan; 102(1):58-63. PMID: 17963805.
      View in: PubMed
    31. Abbas AD, Musa AM. Changing pattern for extremity amputations in University of Maiduguri Teaching Hospital, Nigeria. Niger J Med. 2007 Oct-Dec; 16(4):330-3. PMID: 18080590.
      View in: PubMed
    32. Miller EN, Fadl M, Mohamed HS, Elzein A, Jamieson SE, Cordell HJ, Peacock CS, Fakiola M, Raju M, Khalil EA, Elhassan A, Musa AM, Ibrahim ME, Blackwell JM. Y chromosome lineage- and village-specific genes on chromosomes 1p22 and 6q27 control visceral leishmaniasis in Sudan. PLoS Genet. 2007 May 11; 3(5):e71. PMID: 17500593; PMCID: PMC1866354.
    33. Abubakar MS, Musa AM, Ahmed A, Hussaini IM. The perception and practice of traditional medicine in the treatment of cancers and inflammations by the Hausa and Fulani tribes of Northern Nigeria. J Ethnopharmacol. 2007 May 22; 111(3):625-9. PMID: 17320319.
      View in: PubMed
    34. Khalil EA, Musa AM, Modabber F, El-Hassan AM. Safety and immunogenicity of a candidate vaccine for visceral leishmaniasis (Alum-precipitated autoclaved Leishmania major + BCG) in children: an extended phase II study. Ann Trop Paediatr. 2006 Dec; 26(4):357-61. PMID: 17132302.
      View in: PubMed
    35. Salih MA, Ibrahim ME, Blackwell JM, Miller EN, Khalil EA, ElHassan AM, Musa AM, Mohamed HS. IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan. Genes Immun. 2007 Jan; 8(1):75-8. PMID: 17136124; PMCID: PMC2330095.
    36. Ismail A, Khalil EA, Musa AM, El Hassan IM, Ibrahim ME, Theander TG, El Hassan AM. The pathogenesis of post kala-azar dermal leishmaniasis from the field to the molecule: does ultraviolet light (UVB) radiation play a role? Med Hypotheses. 2006; 66(5):993-9. PMID: 16386855.
      View in: PubMed
    37. Khalil EA, Ahmed AE, Musa AM, Hussein MH. Antimony-induced cerebellar ataxia. Saudi Med J. 2006 Jan; 27(1):90-2. PMID: 16432602.
      View in: PubMed
    38. Elamin EM, Guerbouj S, Musa AM, Guizani I, Khalil EA, Mukhtar MM, Elkadaro AM, Mohamed HS, Ibrahim ME, Abdel Hamid MM, El Azhari M, El Hassan AM. Uncommon clinical presentations of cutaneous leishmaniasis in Sudan. Trans R Soc Trop Med Hyg. 2005 Nov; 99(11):803-8. PMID: 16099005.
      View in: PubMed
    39. Musa AM, Khalil EA, Mahgoub FA, Hamad S, Elkadaru AM, El Hassan AM. Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL). Ann Trop Med Parasitol. 2005 Sep; 99(6):563-9. PMID: 16156969.
      View in: PubMed
    40. Hailu A, Musa AM, Royce C, Wasunna M. Visceral leishmaniasis: new health tools are needed. PLoS Med. 2005 Jul; 2(7):e211. PMID: 16033309; PMCID: PMC1181879.
    41. Khalil EA, Ayed NB, Musa AM, Ibrahim ME, Mukhtar MM, Zijlstra EE, Elhassan IM, Smith PG, Kieny PM, Ghalib HW, Zicker F, Modabber F, Elhassan AM. Dichotomy of protective cellular immune responses to human visceral leishmaniasis. Clin Exp Immunol. 2005 May; 140(2):349-53. PMID: 15807861; PMCID: PMC1809358.
    42. Mahdi M, Elamin EM, Melville SE, Musa AM, Blackwell JM, Mukhtar MM, Elhassan AM, Ibrahim ME. Sudanese mucosal leishmaniasis: isolation of a parasite within the Leishmania donovani complex that differs genotypically from L. donovani causing classical visceral leishmaniasis. Infect Genet Evol. 2005 Jan; 5(1):29-33. PMID: 15567136.
      View in: PubMed
    43. Kamil AA, Khalil EA, Musa AM, Modabber F, Mukhtar MM, Ibrahim ME, Zijlstra EE, Sacks D, Smith PG, Zicker F, El-Hassan AM. Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers. Trans R Soc Trop Med Hyg. 2003 May-Jun; 97(3):365-8. PMID: 15228261.
      View in: PubMed
    44. Zijlstra EE, Musa AM, Khalil EA, el-Hassan IM, el-Hassan AM. Post-kala-azar dermal leishmaniasis. Lancet Infect Dis. 2003 Feb; 3(2):87-98. PMID: 12560194.
      View in: PubMed
    45. Musa AM, Khalil EA, Raheem MA, Zijlstra EE, Ibrahim ME, Elhassan IM, Mukhtar MM, El Hassan AM. The natural history of Sudanese post-kala-azar dermal leishmaniasis: clinical, immunological and prognostic features. Ann Trop Med Parasitol. 2002 Dec; 96(8):765-72. PMID: 12625930.
      View in: PubMed
    46. Musa AM, Asha HA, Veress B. Nephrotic syndrome in Sudanese patients with schistosomiasis mansoni infection. Ann Trop Med Parasitol. 1980 Dec; 74(6):615-8. PMID: 7458465.
      View in: PubMed
    Musa's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description